Hyperkalemia

KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group
Kidney Int. 2020 Oct;98(4S):S1-S115. doi: 10.1016/j.kint.2020.06.019

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia

Bruce S. Spinowitz, Steven Fishbane, Pablo E. Pergola, Simon D. Roger, Edgar V. Lerma, Javed Butler, Stephan von Haehling, Scott H. Adler, June Zhao, Bhupinder Singh, Philip T. Lavin, Peter A. McCullough, Mikhail Kosiborod, David K. Packham
Clin J Am Soc Nephrol . 2019 Jun 7;14(6):798-809

Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors

Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ-Schmidt H, Berman L, Pitt B; OPAL-HK Investigators
N Engl J Med. 2015 Jan 15;372(3):211-21

Sodium zirconium cyclosilicate in hyperkalemia

Packham DK, Rasmussen HS, Lavin PT, El-Shahawy MA, Roger SD, Block G, Qunibi W, Pergola P, Singh B
N Engl J Med. 2015 Jan 15;372(3):222-31
ukidneyisup